Erin M. Olson

1.7k total citations · 1 hit paper
29 papers, 1.2k citations indexed

About

Erin M. Olson is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Erin M. Olson has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Erin M. Olson's work include HER2/EGFR in Cancer Research (8 papers), Cancer Treatment and Pharmacology (5 papers) and Peptidase Inhibition and Analysis (5 papers). Erin M. Olson is often cited by papers focused on HER2/EGFR in Cancer Research (8 papers), Cancer Treatment and Pharmacology (5 papers) and Peptidase Inhibition and Analysis (5 papers). Erin M. Olson collaborates with scholars based in United States, Sweden and United Kingdom. Erin M. Olson's co-authors include Géraldine Dawson, Jamie Winter, Jeffrey Munson, Annette Estes, Katherine Sullivan, Jessica Greenson, Eric P. Winer, Nancy U. Lin, Lakshmi Rajagopal and Kristina M. Adams Waldorf and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer Research.

In The Last Decade

Erin M. Olson

28 papers receiving 1.1k citations

Hit Papers

Long-term Risk of Neuropsychiatric Disease After Exposure... 2019 2026 2021 2023 2019 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-term Risk of Neuropsychiatric Disease After Exposure to Infection In Utero
    2019 179 citations Erin M. Olson, Lakshmi Rajagopal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin M. Olson United States 16 372 312 229 206 202 29 1.2k
Asif Doja Canada 19 291 0.8× 219 0.7× 52 0.2× 241 1.2× 96 0.5× 52 1.4k
Yu-Yu Wu China 15 352 0.9× 376 1.2× 82 0.4× 207 1.0× 184 0.9× 44 1.2k
Xiuhong Li China 20 119 0.3× 201 0.6× 90 0.4× 73 0.4× 85 0.4× 85 1.8k
Carla Johnson United States 15 322 0.9× 146 0.5× 88 0.4× 29 0.1× 300 1.5× 19 1.3k
J. Stolk Netherlands 15 276 0.7× 86 0.3× 174 0.8× 102 0.5× 48 0.2× 41 832
Alison Salt United Kingdom 28 206 0.6× 253 0.8× 593 2.6× 167 0.8× 327 1.6× 64 2.3k
Sarah Thomas United States 20 36 0.1× 179 0.6× 76 0.3× 160 0.8× 215 1.1× 48 1.5k
Ming Lee United States 20 170 0.5× 49 0.2× 64 0.3× 95 0.5× 323 1.6× 69 1.9k
Robin Baker United States 22 93 0.3× 86 0.3× 550 2.4× 93 0.5× 214 1.1× 76 1.6k
Indar Kumar Sharawat India 13 359 1.0× 51 0.2× 143 0.6× 204 1.0× 60 0.3× 124 1.0k

Countries citing papers authored by Erin M. Olson

Since Specialization
Citations

This map shows the geographic impact of Erin M. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin M. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin M. Olson more than expected).

Fields of papers citing papers by Erin M. Olson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin M. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin M. Olson. The network helps show where Erin M. Olson may publish in the future.

Co-authorship network of co-authors of Erin M. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Erin M. Olson. A scholar is included among the top collaborators of Erin M. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin M. Olson. Erin M. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pilla, Rachel, Frédéric Gaschen, James W. Barr, et al.. (2020). Effects of metronidazole on the fecal microbiome and metabolome in healthy dogs. Journal of Veterinary Internal Medicine. 34(5). 1853–1866. 129 indexed citations
2.
Davies, Julian K, et al.. (2020). What proportion of the brain structural and functional abnormalities observed among children with fetal alcohol spectrum disorder is explained by their prenatal alcohol exposure and their other prenatal and postnatal risks?. PubMed. 7. 24 indexed citations
3.
4.
Pilla, Rachel, Blake C. Guard, Jöerg M. Steiner, et al.. (2019). Administration of a Synbiotic Containing Enterococcus faecium Does Not Significantly Alter Fecal Microbiota Richness or Diversity in Dogs With and Without Food-Responsive Chronic Enteropathy. Frontiers in Veterinary Science. 6. 277–277. 26 indexed citations
5.
6.
Waldorf, Kristina M. Adams, et al.. (2018). The Aftermath of Zika: Need for Long-Term Monitoring of Exposed Children. Trends in Microbiology. 26(9). 729–732. 26 indexed citations
7.
Suchodolski, Jan S., Erin M. Olson, Julia B. Honneffer, et al.. (2016). Su1911 Effects of Metronidazole on the Fecal Metabolome in Healthy Dogs: An Untargeted Metabolomics Approach. Gastroenterology. 150(4). S586–S586. 2 indexed citations
8.
Olson, Erin M., Julie Najita, Jessica Sohl, et al.. (2013). Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era. The Breast. 22(4). 525–531. 89 indexed citations
9.
Poi, Ming, Michael Berger, Maryam B. Lustberg, et al.. (2013). Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review. Supportive Care in Cancer. 21(10). 2679–2686. 29 indexed citations
10.
11.
Olson, Erin M.. (2013). When Standard Therapy Fails in Breast Cancer: Current and Future Options for HER2-Positive Disease. Journal of Clinical Trials. 3(1). 1000129–1000129. 6 indexed citations
12.
Ramaswamy, Bhuvaneswari, Jun Zhang, Nathan C. Hall, et al.. (2013). NCI 8609: Interim fluoro-3’-deoxythymidine (FLT) PET imaging findings from the phase I trial of PARP inhibitor veliparib (V) and carboplatin (C) in advanced breast cancer.. Journal of Clinical Oncology. 31(15_suppl). 1023–1023. 1 indexed citations
13.
Damodaran, Senthilkumar & Erin M. Olson. (2012). Targeting the Human Epidermal Growth Factor Receptor 2 Pathway in Breast Cancer. Hospital Practice. 40(4). 7–15. 11 indexed citations
14.
Estes, Annette, Erin M. Olson, Katherine Sullivan, et al.. (2012). Parenting-related stress and psychological distress in mothers of toddlers with autism spectrum disorders. Brain and Development. 35(2). 133–138. 331 indexed citations
15.
Reardon, Joshua, et al.. (2012). Pertuzumab for the treatment of patients with previously untreatedHER2-positive metastatic breast cancer. Drugs of today. 48(11). 713–713. 13 indexed citations
16.
Olson, Erin M., Mahmoud Abdel‐Rasoul, Christina Wu, et al.. (2012). Incidence and risk of central nervous system (CNS) metastases as a site of first recurrence in patients (pts) with HER2-positive (HER2+) breast cancer treated with adjuvant trastuzumab (T).. Journal of Clinical Oncology. 30(15_suppl). 609–609. 2 indexed citations
17.
Olson, Erin M., Nancy U. Lin, Ian E. Krop, & Eric P. Winer. (2011). The ethical use of mandatory research biopsies. Nature Reviews Clinical Oncology. 8(10). 620–625. 53 indexed citations
18.
Olson, Erin M., Nancy U. Lin, Pamela J. DiPiro, et al.. (2011). Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer. Annals of Oncology. 23(1). 93–97. 22 indexed citations
19.
Bauer, Thomas R., Erin M. Olson, Yan Huo, et al.. (2011). Treatment of canine leukocyte adhesion deficiency by foamy virus vectors expressing CD18 from a PGK promoter. Gene Therapy. 18(6). 553–559. 15 indexed citations
20.
Mato, Anthony R., et al.. (2006). Spontaneous tumor lysis syndrome in acute myeloid leukemia: Two cases and a review of the literature. Cancer Biology & Therapy. 5(12). 1614–1617. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asif Doja Breakdown of academic impact, for papers by Yu-Yu Wu Breakdown of academic impact, for papers by Xiuhong Li Breakdown of academic impact, for papers by Carla Johnson Breakdown of academic impact, for papers by J. Stolk Breakdown of academic impact, for papers by Alison Salt Breakdown of academic impact, for papers by Sarah Thomas Breakdown of academic impact, for papers by Ming Lee Breakdown of academic impact, for papers by Robin Baker Breakdown of academic impact, for papers by Indar Kumar Sharawat
Rankless by CCL
2026